HomepageMedicinePharma Pulse 2/4/25: Analyzing Supply Chain Complexities, Navigating Medicare Advantage in 2025 & more Medicine Pharma Pulse 2/4/25: Analyzing Supply Chain Complexities, Navigating Medicare Advantage in 2025 & more admin Posted on February 4, 2025 The latest news for pharma industry insiders. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostBrigade Hotel Ventures secures SEBI approval for ₹900 crore IPO Next PostAnalysis: New Trump tariffs on China more of a 'symbolic' move You Might Also Like Medicine Pharmaceutical Executive: September 2024 Issue (PDF) admin September 18, 2024 Medicine Merck to Acquire Investigational Bispecific Antibody for B-Cell Associated Diseases From Curon Biopharmaceutical admin August 10, 2024 Medicine Approval of Eli Lilly's Alzheimer Drug Donanemab Delayed as FDA Seeks More Information admin March 10, 2024 Medicine Clinical Trial of Keytruda and Lynparza Combination Fails to Meet Primary Endpoint for Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer admin March 22, 2024
Medicine Merck to Acquire Investigational Bispecific Antibody for B-Cell Associated Diseases From Curon Biopharmaceutical admin August 10, 2024
Medicine Approval of Eli Lilly's Alzheimer Drug Donanemab Delayed as FDA Seeks More Information admin March 10, 2024
Medicine Clinical Trial of Keytruda and Lynparza Combination Fails to Meet Primary Endpoint for Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer admin March 22, 2024